Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer

International Journal of Oncology

Volumn 45, Issue 1, 2014, Pages 401-410

  Nishikawa, Rika ^a   Goto, Yusuke ^a   Kojima, Satoko ^b   Enokida, Hideki ^c   Chiyomaru, Takeshi ^c   Kinoshita, Takashi ^a   Sakamoto, Shinichi ^a   Fuse, Miki ^a   Nakagawa, Masayuki ^c   Naya, Yukio ^b   Ichikawa, Tomohiko ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Focal adhesion; LAMC1; microRNA; miR 29; Tumor suppressor

Indexed keywords

MICRORNA 29; LAMININ; LAMININ GAMMA1; MICRORNA; MIRN29 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GENETICS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FOCAL ADHESION; GENE; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMININ GAMMA1 GENE; LUCIFERASE ASSAY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; UPREGULATION; VERY ELDERLY; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LAMININ; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS;

EID: 84902581695     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2437     Document Type: Article

References (38)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Bott SR, Birtle AJ, Taylor CJ and Kirby RS: Prostate cancer management: 2. An update on locally advanced and metastatic disease. Postgrad Med J 79: 643-645, 2003.
3. Timsit MO, Lebret T and Méjean A: Chemotherapy of hormonorefractory and hormonoresistant metastatic prostate cancer. Prog Urol 18 (Suppl 7): S365-S375, 2008 (In French).
4. Carthew RW and Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655, 2009.
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
6. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
7. Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
8. Hobert O: Gene regulation by transcription factors and microRNAs. Science 319: 1785-1786, 2008.
9. Iorio MV and Croce CM: MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856, 2009.
10. Kwak PB, Iwasaki S and Tomari Y: The microRNA pathway and cancer. Cancer Sci 101: 2309-2315, 2010.
11. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
12. Fuse M, Kojima S, Enokida H, et al: Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. J Hum Genet 57: 691-699, 2012.
13. Kojima S, Enokida H, Yoshino H, et al: The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. J Hum Genet 59: 78-87, 2014.
14. Kojima S, Chiyomaru T, Kawakami K, et al: Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 106: 405-413, 2012.
15. Chiyomaru T, Enokida H, Tatarano S, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
16. Fuse M, Nohata N, Kojima S, et al: Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int J Oncol 38: 1093-1101, 2011.
17. Kinoshita T, Nohata N, Hanazawa T, et al: Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. Br J Cancer 109: 2636-2645, 2013.
18. Yamamoto N, Kinoshita T, Nohata N, et al: Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 i n c ervical squamous c ell carcinoma. I nt J Oncol 43: 1855-1863, 2013.
19. Wang Y, Zhang X, Li H, Yu J and Ren X: The role of miRNA-29 family in cancer. Eur J Cell Biol 92: 123-128, 2013.
20. Maurer B, Stanczyk J, Jüngel A, et al: MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62: 1733-1743, 2010.
21. Roderburg C, Urban GW, Bettermann K, et al: Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218, 2011.
22. Yang T, Liang Y, Lin Q, et al: miR-29 mediates TGFbeta1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts. J Cell Biochem 114: 1336-1342, 2013.
23. Nelson CM and Bissell MJ: Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 15: 342-352, 2005.
24. Gassmann P, Enns A and Haier J: Role of tumor cell adhesion and migration in organ-specific metastasis formation. Onkologie 27: 577-582, 2004.
25. White DE, Rayment JH and Muller WJ: Addressing the role of cell adhesion in tumor cell dormancy. Cell Cycle 5: 1756-1759, 2006.
26. Heldin CH, Vanlandewijck M and Moustakas A: Regulation of EMT by TGFbeta in cancer. FEBS Lett 586: 1959-1970, 2012.
27. Skobe M and Fusenig NE: Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA 95: 1050-1055, 1998.
28. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011, 1999.
29. Brown LF, Guidi AJ, Schnitt SJ, et al: Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5: 1041-1056, 1999.
30. Jensen BV, Johansen JS, Skovsgaard T, Brandt J and Teisner B: Extracellular matrix building marked by the N-terminal propeptide of procollagen type I reflect aggressiveness of recurrent breast cancer. Int J Cancer 98: 582-589, 2002.
31. Aumailley M: The laminin family. Cell Adh Migr 7: 48-55, 2013.
32. Tzu J and Marinkovich MP: Bridging structure with function: structural, regulatory, and developmental role of laminins. Int J Biochem Cell Biol 40: 199-214, 2008.
33. Yamaguchi M, Ebihara N, Shima N, et al: Adhesion, migration, and proliferation of cultured human corneal endothelial cells by laminin-5. Invest Ophthalmol Vis Sci 52: 679-684, 2011.
34. Kinoshita T, Hanazawa T, Nohata N, et al: Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 3: 1386-1400, 2012.
35. Nde PN, Simmons KJ, Kleshchenko YY, Pratap S, Lima MF and Villalta F: Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection. Infect Immun 74: 1643-1648, 2006.
36. Toti P, Villanova M, De Felice C, Megha T, Bartolommei S and Tosi P: Expression of laminin 1 and 2 in brain tumor vessels. An immunohistochemical study. J Submicrosc Cytol Pathol 30: 227-230, 1998.
37. Ke HL, Ke RH, Li B, Wang XH, Wang YN and Wang XQ: Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival. Acta Neurochir 155: 165-171, 2013.
38. Kuratomi Y, Nomizu M, Tanaka K, et al: Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells. Br J Cancer 86: 1169-1173, 2002.